These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33764065)

  • 1. The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.
    Robello M; Barresi E; Baglini E; Salerno S; Taliani S; Settimo FD
    J Med Chem; 2021 Apr; 64(7):3508-3545. PubMed ID: 33764065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments in General Methodologies for the Synthesis of α-Ketoamides.
    De Risi C; Pollini GP; Zanirato V
    Chem Rev; 2016 Mar; 116(5):3241-305. PubMed ID: 26881454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitors.
    Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5456-9. PubMed ID: 18835164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chalcone: A Privileged Structure in Medicinal Chemistry.
    Zhuang C; Zhang W; Sheng C; Zhang W; Xing C; Miao Z
    Chem Rev; 2017 Jun; 117(12):7762-7810. PubMed ID: 28488435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
    Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
    Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.
    Barresi E; Robello M; Baglini E; Poggetti V; Viviano M; Salerno S; Da Settimo F; Taliani S
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-ketoamide Phe-Pro isostere as a new core structure for the inhibition of HIV protease.
    Munoz B; Giam CZ; Wong CH
    Bioorg Med Chem; 1994 Oct; 2(10):1085-90. PubMed ID: 7773625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent applications of click chemistry in drug discovery.
    Jiang X; Hao X; Jing L; Wu G; Kang D; Liu X; Zhan P
    Expert Opin Drug Discov; 2019 Aug; 14(8):779-789. PubMed ID: 31094231
    [No Abstract]   [Full Text] [Related]  

  • 9. A versatile synthetic approach to peptidyl privileged structures using a "safety-catch" linker.
    Horton DA; Severinsen R; Kofod-Hansen M; Bourne GT; Smythe ML
    J Comb Chem; 2005; 7(3):421-35. PubMed ID: 15877471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Privileged structures as leads in medicinal chemistry.
    Costantino L; Barlocco D
    Curr Med Chem; 2006; 13(1):65-85. PubMed ID: 16457640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review.
    Bononi G; Lonzi C; Tuccinardi T; Minutolo F; Granchi C
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction between (Z)-arylchlorooximes and α-isocyanoacetamides: a procedure for the synthesis of aryl-α-ketoamide amides.
    Giustiniano M; Mercalli V; Cassese H; Di Maro S; Galli U; Novellino E; Tron GC
    J Org Chem; 2014 Jul; 79(13):6006-14. PubMed ID: 24914772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry of vicinal diaryl scaffold: A mini review.
    Ramajayam R
    Eur J Med Chem; 2019 Jan; 162():1-17. PubMed ID: 30396033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of silicon medicinal chemistry in drug discovery.
    Mills JS; Showell GA
    Expert Opin Investig Drugs; 2004 Sep; 13(9):1149-57. PubMed ID: 15330746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014-2017).
    Zuo X; Huo Z; Kang D; Wu G; Zhou Z; Liu X; Zhan P
    Expert Opin Ther Pat; 2018 Apr; 28(4):299-316. PubMed ID: 29411697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Feb; 164():665-677. PubMed ID: 30654238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta'-Hydroxy-alpha,beta-unsaturated ketones: A new pharmacophore for the design of anticancer drugs. Part 2.
    León LG; Carballo RM; Vega-Hernández MC; Miranda PO; Martín VS; Padrón JI; Padrón JM
    ChemMedChem; 2008 Nov; 3(11):1740-7. PubMed ID: 18846591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclohepta[b]indoles: A Privileged Structure Motif in Natural Products and Drug Design.
    Stempel E; Gaich T
    Acc Chem Res; 2016 Nov; 49(11):2390-2402. PubMed ID: 27709885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Assay Design on Medicinal Chemistry: Case Studies.
    Born JR; Chenniappan VK; Davis DP; Dahlin JL; Marugan JJ; Patnaik S
    SLAS Discov; 2021 Dec; 26(10):1243-1255. PubMed ID: 34225522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.